In this study, expression of DNA repair proteins MLH1, MSH2 and MGMT were investigated in early-stage NSCLC and precursor lesions using tissue microarrays (TMAs) and the results have been correlated with clinicopathological parameters and patient survival. This evidence concerns the gene MGMT and non-small cell lung carcinoma.